nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Optic neuritis—Quinidine barbiturate—malaria	0.00989	0.00989	CcSEcCtD
Deferoxamine—Aphasia—Quinidine barbiturate—malaria	0.00938	0.00938	CcSEcCtD
Deferoxamine—Scotoma—Quinidine—malaria	0.00887	0.00887	CcSEcCtD
Deferoxamine—Scotoma—Quinine—malaria	0.00887	0.00887	CcSEcCtD
Deferoxamine—Scotoma—Quinidine barbiturate—malaria	0.00801	0.00801	CcSEcCtD
Deferoxamine—Scotoma—Pentoxifylline—malaria	0.00799	0.00799	CcSEcCtD
Deferoxamine—Bone disorder—Quinidine—malaria	0.00746	0.00746	CcSEcCtD
Deferoxamine—Bone disorder—Quinine—malaria	0.00746	0.00746	CcSEcCtD
Deferoxamine—Leukopenia—Pyrimethamine—malaria	0.00698	0.00698	CcSEcCtD
Deferoxamine—Hallucination—Proguanil—malaria	0.00694	0.00694	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Sulfadiazine—malaria	0.00692	0.00692	CcSEcCtD
Deferoxamine—Bone disorder—Quinidine barbiturate—malaria	0.00673	0.00673	CcSEcCtD
Deferoxamine—Anaphylactic shock—Pyrimethamine—malaria	0.00636	0.00636	CcSEcCtD
Deferoxamine—Immune system disorder—Proguanil—malaria	0.0063	0.0063	CcSEcCtD
Deferoxamine—Mediastinal disorder—Proguanil—malaria	0.00629	0.00629	CcSEcCtD
Deferoxamine—Thrombocytopenia—Pyrimethamine—malaria	0.00623	0.00623	CcSEcCtD
Deferoxamine—Erythema—Proguanil—malaria	0.00608	0.00608	CcSEcCtD
Deferoxamine—Injection site reaction—Quinidine barbiturate—malaria	0.00605	0.00605	CcSEcCtD
Deferoxamine—Swelling—Clindamycin—malaria	0.00565	0.00565	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Pentoxifylline—malaria	0.00558	0.00558	CcSEcCtD
Deferoxamine—Renal failure acute—Quinidine—malaria	0.0053	0.0053	CcSEcCtD
Deferoxamine—Renal failure acute—Quinine—malaria	0.0053	0.0053	CcSEcCtD
Deferoxamine—Visual disturbance—Quinine—malaria	0.00516	0.00516	CcSEcCtD
Deferoxamine—Visual disturbance—Quinidine—malaria	0.00516	0.00516	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Clindamycin—malaria	0.00515	0.00515	CcSEcCtD
Deferoxamine—Renal impairment—Quinine—malaria	0.00514	0.00514	CcSEcCtD
Deferoxamine—Renal impairment—Quinidine—malaria	0.00514	0.00514	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00514	0.00514	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Sulfadiazine—malaria	0.00506	0.00506	CcSEcCtD
Deferoxamine—Swelling—Pentoxifylline—malaria	0.005	0.005	CcSEcCtD
Deferoxamine—Nervous system disorder—Proguanil—malaria	0.00486	0.00486	CcSEcCtD
Deferoxamine—Skin disorder—Proguanil—malaria	0.00482	0.00482	CcSEcCtD
Deferoxamine—Renal failure acute—Quinidine barbiturate—malaria	0.00478	0.00478	CcSEcCtD
Deferoxamine—Hypersensitivity—Pyrimethamine—malaria	0.00469	0.00469	CcSEcCtD
Deferoxamine—Visual disturbance—Quinidine barbiturate—malaria	0.00466	0.00466	CcSEcCtD
Deferoxamine—Renal impairment—Quinidine barbiturate—malaria	0.00464	0.00464	CcSEcCtD
Deferoxamine—Hallucination—Sulfadiazine—malaria	0.00461	0.00461	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Pentoxifylline—malaria	0.00455	0.00455	CcSEcCtD
Deferoxamine—Tinnitus—Sulfadiazine—malaria	0.00432	0.00432	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Proguanil—malaria	0.00428	0.00428	CcSEcCtD
Deferoxamine—Eosinophilia—Clindamycin—malaria	0.00427	0.00427	CcSEcCtD
Deferoxamine—Asthma—Quinine—malaria	0.00423	0.00423	CcSEcCtD
Deferoxamine—Asthma—Quinidine—malaria	0.00423	0.00423	CcSEcCtD
Deferoxamine—Abdominal discomfort—Clindamycin—malaria	0.00413	0.00413	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Proguanil—malaria	0.00405	0.00405	CcSEcCtD
Deferoxamine—Vomiting—Pyrimethamine—malaria	0.00405	0.00405	CcSEcCtD
Deferoxamine—Dysuria—Clindamycin—malaria	0.00403	0.00403	CcSEcCtD
Deferoxamine—Abdominal pain—Proguanil—malaria	0.00392	0.00392	CcSEcCtD
Deferoxamine—Body temperature increased—Proguanil—malaria	0.00392	0.00392	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Dapsone—malaria	0.00389	0.00389	CcSEcCtD
Deferoxamine—Asthma—Quinidine barbiturate—malaria	0.00382	0.00382	CcSEcCtD
Deferoxamine—Renal failure—Quinidine—malaria	0.00371	0.00371	CcSEcCtD
Deferoxamine—Renal failure—Quinine—malaria	0.00371	0.00371	CcSEcCtD
Deferoxamine—Abdominal discomfort—Pentoxifylline—malaria	0.00365	0.00365	CcSEcCtD
Deferoxamine—Leukopenia—Sulfadiazine—malaria	0.00361	0.00361	CcSEcCtD
Deferoxamine—Convulsion—Sulfadiazine—malaria	0.00349	0.00349	CcSEcCtD
Deferoxamine—Bradycardia—Quinidine—malaria	0.00345	0.00345	CcSEcCtD
Deferoxamine—Bradycardia—Quinine—malaria	0.00345	0.00345	CcSEcCtD
Deferoxamine—Arthralgia—Sulfadiazine—malaria	0.00343	0.00343	CcSEcCtD
Deferoxamine—Infestation—Pentoxifylline—malaria	0.0034	0.0034	CcSEcCtD
Deferoxamine—Infestation NOS—Pentoxifylline—malaria	0.0034	0.0034	CcSEcCtD
Deferoxamine—Diarrhoea—Proguanil—malaria	0.00339	0.00339	CcSEcCtD
Deferoxamine—Renal failure—Quinidine barbiturate—malaria	0.00334	0.00334	CcSEcCtD
Deferoxamine—Urinary tract disorder—Quinidine—malaria	0.00334	0.00334	CcSEcCtD
Deferoxamine—Urinary tract disorder—Quinine—malaria	0.00334	0.00334	CcSEcCtD
Deferoxamine—Tinnitus—Dapsone—malaria	0.00333	0.00333	CcSEcCtD
Deferoxamine—Urethral disorder—Quinidine—malaria	0.00332	0.00332	CcSEcCtD
Deferoxamine—Urethral disorder—Quinine—malaria	0.00332	0.00332	CcSEcCtD
Deferoxamine—Anaphylactic shock—Sulfadiazine—malaria	0.00329	0.00329	CcSEcCtD
Deferoxamine—Visual impairment—Quinidine—malaria	0.00326	0.00326	CcSEcCtD
Deferoxamine—Visual impairment—Quinine—malaria	0.00326	0.00326	CcSEcCtD
Deferoxamine—Thrombocytopenia—Sulfadiazine—malaria	0.00322	0.00322	CcSEcCtD
Deferoxamine—Eye disorder—Quinidine—malaria	0.00316	0.00316	CcSEcCtD
Deferoxamine—Eye disorder—Quinine—malaria	0.00316	0.00316	CcSEcCtD
Deferoxamine—Tinnitus—Quinidine—malaria	0.00316	0.00316	CcSEcCtD
Deferoxamine—Tinnitus—Quinine—malaria	0.00316	0.00316	CcSEcCtD
Deferoxamine—Vomiting—Proguanil—malaria	0.00315	0.00315	CcSEcCtD
Deferoxamine—Bradycardia—Quinidine barbiturate—malaria	0.00311	0.00311	CcSEcCtD
Deferoxamine—Headache—Proguanil—malaria	0.00311	0.00311	CcSEcCtD
Deferoxamine—Erythema—Dapsone—malaria	0.0031	0.0031	CcSEcCtD
Deferoxamine—Immune system disorder—Quinidine—malaria	0.00306	0.00306	CcSEcCtD
Deferoxamine—Immune system disorder—Quinine—malaria	0.00306	0.00306	CcSEcCtD
Deferoxamine—Mediastinal disorder—Quinine—malaria	0.00305	0.00305	CcSEcCtD
Deferoxamine—Mediastinal disorder—Quinidine—malaria	0.00305	0.00305	CcSEcCtD
Deferoxamine—Hallucination—Quinidine barbiturate—malaria	0.00304	0.00304	CcSEcCtD
Deferoxamine—Urinary tract disorder—Quinidine barbiturate—malaria	0.00302	0.00302	CcSEcCtD
Deferoxamine—Erythema—Clindamycin—malaria	0.003	0.003	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Sulfadiazine—malaria	0.003	0.003	CcSEcCtD
Deferoxamine—Urethral disorder—Quinidine barbiturate—malaria	0.00299	0.00299	CcSEcCtD
Deferoxamine—Erythema—Quinidine—malaria	0.00295	0.00295	CcSEcCtD
Deferoxamine—Erythema—Quinine—malaria	0.00295	0.00295	CcSEcCtD
Deferoxamine—Nausea—Proguanil—malaria	0.00295	0.00295	CcSEcCtD
Deferoxamine—Visual impairment—Quinidine barbiturate—malaria	0.00294	0.00294	CcSEcCtD
Deferoxamine—Vision blurred—Dapsone—malaria	0.00293	0.00293	CcSEcCtD
Deferoxamine—Muscle spasms—Clindamycin—malaria	0.00289	0.00289	CcSEcCtD
Deferoxamine—Eye disorder—Quinidine barbiturate—malaria	0.00285	0.00285	CcSEcCtD
Deferoxamine—Tinnitus—Quinidine barbiturate—malaria	0.00285	0.00285	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Sulfadiazine—malaria	0.00284	0.00284	CcSEcCtD
Deferoxamine—Vision blurred—Quinine—malaria	0.00278	0.00278	CcSEcCtD
Deferoxamine—Vision blurred—Quinidine—malaria	0.00278	0.00278	CcSEcCtD
Deferoxamine—Immune system disorder—Quinidine barbiturate—malaria	0.00276	0.00276	CcSEcCtD
Deferoxamine—Immune system disorder—Pentoxifylline—malaria	0.00275	0.00275	CcSEcCtD
Deferoxamine—Mediastinal disorder—Quinidine barbiturate—malaria	0.00275	0.00275	CcSEcCtD
Deferoxamine—Arrhythmia—Pentoxifylline—malaria	0.00272	0.00272	CcSEcCtD
Deferoxamine—Angioedema—Quinidine—malaria	0.00269	0.00269	CcSEcCtD
Deferoxamine—Angioedema—Quinine—malaria	0.00269	0.00269	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Sulfadiazine—malaria	0.00269	0.00269	CcSEcCtD
Deferoxamine—Leukopenia—Clindamycin—malaria	0.00269	0.00269	CcSEcCtD
Deferoxamine—Erythema—Quinidine barbiturate—malaria	0.00266	0.00266	CcSEcCtD
Deferoxamine—Erythema—Pentoxifylline—malaria	0.00265	0.00265	CcSEcCtD
Deferoxamine—Leukopenia—Quinine—malaria	0.00264	0.00264	CcSEcCtD
Deferoxamine—Leukopenia—Quinidine—malaria	0.00264	0.00264	CcSEcCtD
Deferoxamine—Urticaria—Sulfadiazine—malaria	0.00261	0.00261	CcSEcCtD
Deferoxamine—Abdominal pain—Sulfadiazine—malaria	0.0026	0.0026	CcSEcCtD
Deferoxamine—Body temperature increased—Sulfadiazine—malaria	0.0026	0.0026	CcSEcCtD
Deferoxamine—Convulsion—Quinidine—malaria	0.00255	0.00255	CcSEcCtD
Deferoxamine—Convulsion—Quinine—malaria	0.00255	0.00255	CcSEcCtD
Deferoxamine—Muscle spasms—Pentoxifylline—malaria	0.00255	0.00255	CcSEcCtD
Deferoxamine—Myalgia—Quinine—malaria	0.00251	0.00251	CcSEcCtD
Deferoxamine—Myalgia—Quinidine—malaria	0.00251	0.00251	CcSEcCtD
Deferoxamine—Vision blurred—Quinidine barbiturate—malaria	0.00251	0.00251	CcSEcCtD
Deferoxamine—Vision blurred—Pentoxifylline—malaria	0.0025	0.0025	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00249	0.00249	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00249	0.00249	CcSEcCtD
Deferoxamine—Tachycardia—Dapsone—malaria	0.00247	0.00247	CcSEcCtD
Deferoxamine—Anaphylactic shock—Clindamycin—malaria	0.00245	0.00245	CcSEcCtD
Deferoxamine—Angioedema—Quinidine barbiturate—malaria	0.00243	0.00243	CcSEcCtD
Deferoxamine—Angioedema—Pentoxifylline—malaria	0.00243	0.00243	CcSEcCtD
Deferoxamine—Hypersensitivity—Sulfadiazine—malaria	0.00242	0.00242	CcSEcCtD
Deferoxamine—Oedema—Quinine—malaria	0.0024	0.0024	CcSEcCtD
Deferoxamine—Oedema—Quinidine—malaria	0.0024	0.0024	CcSEcCtD
Deferoxamine—Thrombocytopenia—Clindamycin—malaria	0.0024	0.0024	CcSEcCtD
Deferoxamine—Leukopenia—Quinidine barbiturate—malaria	0.00238	0.00238	CcSEcCtD
Deferoxamine—Leukopenia—Pentoxifylline—malaria	0.00238	0.00238	CcSEcCtD
Deferoxamine—Shock—Quinidine—malaria	0.00237	0.00237	CcSEcCtD
Deferoxamine—Shock—Quinine—malaria	0.00237	0.00237	CcSEcCtD
Deferoxamine—Nervous system disorder—Quinine—malaria	0.00236	0.00236	CcSEcCtD
Deferoxamine—Nervous system disorder—Quinidine—malaria	0.00236	0.00236	CcSEcCtD
Deferoxamine—Thrombocytopenia—Quinine—malaria	0.00235	0.00235	CcSEcCtD
Deferoxamine—Thrombocytopenia—Quinidine—malaria	0.00235	0.00235	CcSEcCtD
Deferoxamine—Tachycardia—Quinine—malaria	0.00235	0.00235	CcSEcCtD
Deferoxamine—Tachycardia—Quinidine—malaria	0.00235	0.00235	CcSEcCtD
Deferoxamine—Skin disorder—Quinidine—malaria	0.00234	0.00234	CcSEcCtD
Deferoxamine—Skin disorder—Quinine—malaria	0.00234	0.00234	CcSEcCtD
Deferoxamine—Pruritus—Sulfadiazine—malaria	0.00233	0.00233	CcSEcCtD
Deferoxamine—Convulsion—Quinidine barbiturate—malaria	0.0023	0.0023	CcSEcCtD
Deferoxamine—Convulsion—Pentoxifylline—malaria	0.0023	0.0023	CcSEcCtD
Deferoxamine—Hypotension—Clindamycin—malaria	0.00229	0.00229	CcSEcCtD
Deferoxamine—Arthralgia—Quinidine barbiturate—malaria	0.00226	0.00226	CcSEcCtD
Deferoxamine—Myalgia—Quinidine barbiturate—malaria	0.00226	0.00226	CcSEcCtD
Deferoxamine—Myalgia—Pentoxifylline—malaria	0.00226	0.00226	CcSEcCtD
Deferoxamine—Diarrhoea—Sulfadiazine—malaria	0.00225	0.00225	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00225	0.00225	CcSEcCtD
Deferoxamine—Hypotension—Quinine—malaria	0.00225	0.00225	CcSEcCtD
Deferoxamine—Hypotension—Quinidine—malaria	0.00225	0.00225	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00224	0.00224	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Quinine—malaria	0.00219	0.00219	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Quinidine—malaria	0.00219	0.00219	CcSEcCtD
Deferoxamine—Dyspnoea—Clindamycin—malaria	0.00219	0.00219	CcSEcCtD
Deferoxamine—Oedema—Quinidine barbiturate—malaria	0.00217	0.00217	CcSEcCtD
Deferoxamine—Oedema—Pentoxifylline—malaria	0.00217	0.00217	CcSEcCtD
Deferoxamine—Anaphylactic shock—Pentoxifylline—malaria	0.00217	0.00217	CcSEcCtD
Deferoxamine—Infection—Pentoxifylline—malaria	0.00215	0.00215	CcSEcCtD
Deferoxamine—Dyspnoea—Quinine—malaria	0.00214	0.00214	CcSEcCtD
Deferoxamine—Dyspnoea—Quinidine—malaria	0.00214	0.00214	CcSEcCtD
Deferoxamine—Shock—Quinidine barbiturate—malaria	0.00213	0.00213	CcSEcCtD
Deferoxamine—Shock—Pentoxifylline—malaria	0.00213	0.00213	CcSEcCtD
Deferoxamine—Nervous system disorder—Quinidine barbiturate—malaria	0.00213	0.00213	CcSEcCtD
Deferoxamine—Thrombocytopenia—Quinidine barbiturate—malaria	0.00212	0.00212	CcSEcCtD
Deferoxamine—Thrombocytopenia—Pentoxifylline—malaria	0.00212	0.00212	CcSEcCtD
Deferoxamine—Tachycardia—Quinidine barbiturate—malaria	0.00212	0.00212	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Clindamycin—malaria	0.00212	0.00212	CcSEcCtD
Deferoxamine—Tachycardia—Pentoxifylline—malaria	0.00211	0.00211	CcSEcCtD
Deferoxamine—Skin disorder—Quinidine barbiturate—malaria	0.00211	0.00211	CcSEcCtD
Deferoxamine—Skin disorder—Pentoxifylline—malaria	0.0021	0.0021	CcSEcCtD
Deferoxamine—Pain—Clindamycin—malaria	0.0021	0.0021	CcSEcCtD
Deferoxamine—Vomiting—Sulfadiazine—malaria	0.00209	0.00209	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Quinidine—malaria	0.00208	0.00208	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Quinine—malaria	0.00208	0.00208	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dapsone—malaria	0.00207	0.00207	CcSEcCtD
Deferoxamine—Headache—Sulfadiazine—malaria	0.00206	0.00206	CcSEcCtD
Deferoxamine—Hypotension—Quinidine barbiturate—malaria	0.00203	0.00203	CcSEcCtD
Deferoxamine—Hypotension—Pentoxifylline—malaria	0.00202	0.00202	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Clindamycin—malaria	0.002	0.002	CcSEcCtD
Deferoxamine—Body temperature increased—Dapsone—malaria	0.002	0.002	CcSEcCtD
Deferoxamine—Abdominal pain—Dapsone—malaria	0.002	0.002	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00198	0.00198	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00197	0.00197	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Quinine—malaria	0.00197	0.00197	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Quinidine—malaria	0.00197	0.00197	CcSEcCtD
Deferoxamine—Nausea—Sulfadiazine—malaria	0.00195	0.00195	CcSEcCtD
Deferoxamine—Urticaria—Clindamycin—malaria	0.00195	0.00195	CcSEcCtD
Deferoxamine—Abdominal pain—Clindamycin—malaria	0.00194	0.00194	CcSEcCtD
Deferoxamine—Body temperature increased—Clindamycin—malaria	0.00194	0.00194	CcSEcCtD
Deferoxamine—Dyspnoea—Quinidine barbiturate—malaria	0.00193	0.00193	CcSEcCtD
Deferoxamine—Dyspnoea—Pentoxifylline—malaria	0.00193	0.00193	CcSEcCtD
Deferoxamine—Urticaria—Quinidine—malaria	0.00191	0.00191	CcSEcCtD
Deferoxamine—Urticaria—Quinine—malaria	0.00191	0.00191	CcSEcCtD
Deferoxamine—Body temperature increased—Quinine—malaria	0.0019	0.0019	CcSEcCtD
Deferoxamine—Body temperature increased—Quinidine—malaria	0.0019	0.0019	CcSEcCtD
Deferoxamine—Abdominal pain—Quinine—malaria	0.0019	0.0019	CcSEcCtD
Deferoxamine—Abdominal pain—Quinidine—malaria	0.0019	0.0019	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00187	0.00187	CcSEcCtD
Deferoxamine—Pain—Quinidine barbiturate—malaria	0.00186	0.00186	CcSEcCtD
Deferoxamine—Hypersensitivity—Clindamycin—malaria	0.00181	0.00181	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00177	0.00177	CcSEcCtD
Deferoxamine—Hypersensitivity—Quinine—malaria	0.00177	0.00177	CcSEcCtD
Deferoxamine—Hypersensitivity—Quinidine—malaria	0.00177	0.00177	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Pentoxifylline—malaria	0.00177	0.00177	CcSEcCtD
Deferoxamine—Pruritus—Clindamycin—malaria	0.00173	0.00173	CcSEcCtD
Deferoxamine—Urticaria—Quinidine barbiturate—malaria	0.00172	0.00172	CcSEcCtD
Deferoxamine—Urticaria—Pentoxifylline—malaria	0.00172	0.00172	CcSEcCtD
Deferoxamine—Abdominal pain—Quinidine barbiturate—malaria	0.00172	0.00172	CcSEcCtD
Deferoxamine—Body temperature increased—Quinidine barbiturate—malaria	0.00172	0.00172	CcSEcCtD
Deferoxamine—Abdominal pain—Pentoxifylline—malaria	0.00171	0.00171	CcSEcCtD
Deferoxamine—Body temperature increased—Pentoxifylline—malaria	0.00171	0.00171	CcSEcCtD
Deferoxamine—Pruritus—Quinine—malaria	0.0017	0.0017	CcSEcCtD
Deferoxamine—Pruritus—Quinidine—malaria	0.0017	0.0017	CcSEcCtD
Deferoxamine—Diarrhoea—Clindamycin—malaria	0.00168	0.00168	CcSEcCtD
Deferoxamine—Diarrhoea—Quinine—malaria	0.00165	0.00165	CcSEcCtD
Deferoxamine—Diarrhoea—Quinidine—malaria	0.00165	0.00165	CcSEcCtD
Deferoxamine—Dizziness—Clindamycin—malaria	0.00162	0.00162	CcSEcCtD
Deferoxamine—Vomiting—Dapsone—malaria	0.00161	0.00161	CcSEcCtD
Deferoxamine—Hypersensitivity—Quinidine barbiturate—malaria	0.0016	0.0016	CcSEcCtD
Deferoxamine—Hypersensitivity—Pentoxifylline—malaria	0.0016	0.0016	CcSEcCtD
Deferoxamine—Dizziness—Quinine—malaria	0.00159	0.00159	CcSEcCtD
Deferoxamine—Dizziness—Quinidine—malaria	0.00159	0.00159	CcSEcCtD
Deferoxamine—Headache—Dapsone—malaria	0.00159	0.00159	CcSEcCtD
Deferoxamine—Vomiting—Clindamycin—malaria	0.00156	0.00156	CcSEcCtD
Deferoxamine—Headache—Clindamycin—malaria	0.00154	0.00154	CcSEcCtD
Deferoxamine—Pruritus—Quinidine barbiturate—malaria	0.00154	0.00154	CcSEcCtD
Deferoxamine—Pruritus—Pentoxifylline—malaria	0.00153	0.00153	CcSEcCtD
Deferoxamine—Vomiting—Quinidine—malaria	0.00153	0.00153	CcSEcCtD
Deferoxamine—Vomiting—Quinine—malaria	0.00153	0.00153	CcSEcCtD
Deferoxamine—Headache—Quinine—malaria	0.00151	0.00151	CcSEcCtD
Deferoxamine—Headache—Quinidine—malaria	0.00151	0.00151	CcSEcCtD
Deferoxamine—Nausea—Dapsone—malaria	0.0015	0.0015	CcSEcCtD
Deferoxamine—Diarrhoea—Quinidine barbiturate—malaria	0.00148	0.00148	CcSEcCtD
Deferoxamine—Diarrhoea—Pentoxifylline—malaria	0.00148	0.00148	CcSEcCtD
Deferoxamine—Nausea—Clindamycin—malaria	0.00146	0.00146	CcSEcCtD
Deferoxamine—Dizziness—Quinidine barbiturate—malaria	0.00143	0.00143	CcSEcCtD
Deferoxamine—Dizziness—Pentoxifylline—malaria	0.00143	0.00143	CcSEcCtD
Deferoxamine—Nausea—Quinidine—malaria	0.00143	0.00143	CcSEcCtD
Deferoxamine—Nausea—Quinine—malaria	0.00143	0.00143	CcSEcCtD
Deferoxamine—Vomiting—Quinidine barbiturate—malaria	0.00138	0.00138	CcSEcCtD
Deferoxamine—Vomiting—Pentoxifylline—malaria	0.00138	0.00138	CcSEcCtD
Deferoxamine—Headache—Quinidine barbiturate—malaria	0.00136	0.00136	CcSEcCtD
Deferoxamine—Headache—Pentoxifylline—malaria	0.00136	0.00136	CcSEcCtD
Deferoxamine—Nausea—Quinidine barbiturate—malaria	0.00129	0.00129	CcSEcCtD
Deferoxamine—Nausea—Pentoxifylline—malaria	0.00129	0.00129	CcSEcCtD
